首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Health affairs scholar

缩写:HLTH AFF SCH

ISSN:N/A

e-ISSN:2976-5390

IF/分区:4.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引711条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
[This corrects the article DOI: 10.1093/haschl/qxaf187.]. © The Author(s) 2026. Published by Oxford University Press on behalf of Project HOPE - The Peo...
Roslyn C Murray,Christopher M Whaley Roslyn C Murray
Introduction: Reference-based pricing has shown promise in reducing hospital prices and spending for state employee health plans. However, its impact among other commercially insured populations is not well understood. ...
Alice Abernathy,Brandon Wagner,Kelly Cleland Alice Abernathy
Introduction: The US Supreme Court ruling in Dobbs v Jackson Women's Health Organization (Dobbs) substantially altered abortion access nationwide, underscoring the importance of emergency contraception as the last opportu...
Luca Maini,Mai Anh Tran,Josh Feng Luca Maini
Background: The elasticity of pharmaceutical innovation with respect to market size is a key input for evaluating pricing reforms, yet published estimates vary widely. ...
Jad F Zeitouni,Xiaodan Hu,Sanket S Dhruva et al. Jad F Zeitouni et al.
In January 2026, the Centers for Medicare and Medicaid Services (CMS) implemented a major overhaul of Medicare reimbursement for skin substitutes in an effort to curb runaway spending. Between 2019 and 2024, annual Medicare Part B spending ...
Jose F Figueroa,Loren Adler,William B Feldman et al. Jose F Figueroa et al.
Health policy is undergoing a period of rapid transformation, driven by major health reforms, changing market structures, pharmaceutical policy developments, technological innovation, and evolving models of care delivery. These changes have...
Caroline G Borden,Renhao Wang,Alexander O Everhart et al. Caroline G Borden et al.
Introduction: The Inflation Reduction Act (IRA) capped out-of-pocket (OOP) insulin spending at $35 for Medicare Part D beneficiaries in 2023. Studies have shown lower per-prescription insulin spending after the IRA but le...
Rena M Conti,Mathew Alexander,Eric J Evans Rena M Conti
Introduction: Developing novel antibiotics to replace ineffective existing ones is a priority policy objective. The Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) is the largest global public-private initiat...
Benjamin Rader,Autumn H Gertz,Jonathan H Cantor et al. Benjamin Rader et al.
Introduction: Generative AI (genAI) is rapidly entering healthcare, but public comfort may vary in ways that could undermine equitable adoption. Methods: ...
Maria Olivia Pozzolo Pedro,Nidhi Binoy,Dylanis López Ruiz et al. Maria Olivia Pozzolo Pedro et al.
Background: The impact of government financial assistance and substance use is contested by 2 competing hypotheses: the "income effect" posits that cash transfers could facilitate substance consumption, while the "stress-...